Hannah Dry
Impact in
-
- HER2/EGFR in Cancer Research
- Cancer Immunotherapy and Biomarkers
- Cancer Treatment and Pharmacology
- CAR-T cell therapy research
Papers in
- Oncology 8
- Cancer Immunotherapy and Biomarkers 4
- HER2/EGFR in Cancer Research 3
- Cancer Treatment and Pharmacology 2
-
- PI3K/AKT/mTOR signaling in cancer 3
- Co-authors
- Darren A.E. Cross (1 shared paper)Dario R. Alessi (1 shared paper)Eeva Sommer (1 shared paper)Sylvie M. Guichard (1 shared paper)B. R. Davies (1 shared paper)Ross Stewart (4 shared papers)Ana T. Nunes (4 shared papers)Vatsala Karwe (2 shared papers)
- Journals
- Journal of Clinical Oncology (4 papers)Cancer Research (2 papers)Biochemical Journal (1 paper)Therapeutic Advances in Medical Oncology (1 paper)Leukemia (1 paper)
- Partner nations
- United KingdomUnited StatesSouth Korea
In The Last Decade
Hannah Dry
12 papers receiving 292 citations
Peers
Comparison fields: 5 of 44
- Oncology 166
- Cancer Research 35
- Molecular Biology 143
- Genetics 20
- Radiology, Nuclear Medicine and Imaging 42
Countries citing papers authored by Hannah Dry
This map shows the geographic impact of Hannah Dry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hannah Dry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hannah Dry more than expected).
Fields of papers citing papers by Hannah Dry
This network shows the impact of papers produced by Hannah Dry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hannah Dry. The network helps show where Hannah Dry may publish in the future.
Co-authors
The 25 scholars most cited alongside Hannah Dry, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 127 | |
| 2 | 2021 | 79 | |
| 3 | 2022 | 32 | |
| 4 | 2022 | 17 | |
| 5 | 2024 | 16 | |
| 6 | 2022 | 10 | |
| 7 | 2020 | 3 | |
| 8 | 2021 | 3 | |
| 9 | 2022 | 3 | |
| 10 | 2024 | 2 | |
| 11 | 2013 | 2 | |
| 12 | 2021 | 1 |
About Hannah Dry
Hannah Dry is a scholar working on Oncology, Molecular Biology, Surgery, Genetics and Pathology and Forensic Medicine, having authored 12 papers that have together received 295 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (4 papers), HER2/EGFR in Cancer Research (3 papers), PI3K/AKT/mTOR signaling in cancer (3 papers), Lymphoma Diagnosis and Treatment (2 papers), Cancer Treatment and Pharmacology (2 papers), Chronic Lymphocytic Leukemia Research (2 papers), Bladder and Urothelial Cancer Treatments (2 papers) and Radiopharmaceutical Chemistry and Applications (2 papers). The work is most often cited by research in Oncology (166 citations), Cancer Research (35 citations), Molecular Biology (143 citations), Genetics (20 citations) and Radiology, Nuclear Medicine and Imaging (42 citations). Hannah Dry has collaborated with scholars based in United Kingdom, United States and South Korea. Frequent co-authors include Darren A.E. Cross, Dario R. Alessi, Eeva Sommer, Sylvie M. Guichard, B. R. Davies, Ross Stewart, Ana T. Nunes, Vatsala Karwe, Peter Schmid and Seock‐Ah Im. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Biochemical Journal, Therapeutic Advances in Medical Oncology and Leukemia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.